Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease

NCT00054613 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT00054613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease
Lead sponsor
Mallinckrodt
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
March 31, 2004
Enrollment
72
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease